Personalized Digital Support for Chronic Disease Management

Poor medication adherence continues to undermine patient outcomes, healthcare investments, and treatment success globally. According to the World Health Organization (WHO), approximately 50% of patients with chronic conditions in developed countries do not take medications as prescribed.

As chronic diseases rise and treatment regimens become more complex, traditional support programs struggle to drive long-term engagement. Patients face barriers including treatment complexity, refill challenges, side effects, and competing priorities that can impact adherence and therapy persistence.

To address these challenges, Merck KGaA partnered with Medisafe to deploy a Digital Drug Companion across Brazil, Russia, and Mexico. The program delivered personalized medication management, condition-specific education, and adherence support tailored to each patient's needs and daily routine.

The results demonstrated that when support is personalized and integrated into patients' daily lives, adherence improves, engagement increases, and patient satisfaction rises across diverse global populations.

Digital Support Drives Better Engagement

Across cardiology, diabetes, and thyroid patient populations, several key themes emerged:

• Personalized support programs improve patient engagement by addressing condition-specific challenges and treatment needs.
• Educational content helps patients better understand their condition, resulting in higher patient buy-in
• Digital medication management tools simplify complex regimens and reduce barriers to adherence.
• Support that fits naturally into daily routines improves both the patient experience and medication adherence.

The findings reinforce that personalized digital health programs can drive behavior change, improve patient engagement, strengthen medication adherence, and support better long-term outcomes.

Beyond Medication Reminders

The study demonstrates that effective patient engagement requires more than medication reminders alone. While reminders remain important, the strongest results came from combining medication management with condition-specific education and personalized support. These findings offer valuable insights for organizations looking to improve adherence and patient outcomes at scale.

Turning Personalized Engagement Into Better Outcomes

Built on 12+ years of real-world patient behavior data, Medisafe helps pharmaceutical organizations create personalized support experiences that adapt to patient needs.

By combining medication management, educational content, behavioral intelligence, and digital engagement tools, Medisafe enables brands to support patients throughout their treatment journey.

The result is improved adherence and better long-term outcomes across diverse patient populations.

New Insights Into Digital Patient Engagement

Medisafe's latest research explores how personalized digital support influences medication adherence and patient engagement across chronic disease populations.

The findings provide pharmaceutical organizations with actionable insights into the role of behavioral support, patient education, and personalized engagement in improving outcomes at scale.